Here’s Why SINA Corp, Microchip Technology, Endo International & Other Stocks Are on the Move Today

WebMD Traffic Ailing

WebMD Health Corp. (NASDAQ:WBMD) has lost more than 8%, even though the company beat top- and bottom-line estimates for the second quarter. While EPS of $0.39 and revenue of $167.58 million came in $0.01 and $2.18 million ahead of estimates, respectively, a 6% decline in traffic, to 199 million unique visitors, hurt the stock. For the ongoing quarter, the company’s management estimates revenues of $168 million to $171 million and net income of $17 million to $18.5 million. For the full year, the guidance stands for net income of $82 million to $89.5 million, or $1.78 to $1.90 per share, below the current consensus estimate of $1.92 per share. A total of 26 funds from our database held long equity stakes in WebMD Health Corp. (NASDAQ:WBMD) at the end of March. The largest position was held Michael Lowenstein’s Kensico Capital, which owned 5.1 million shares, according to its last 13F filing.

Microchip Technology Posts Record Figures

Back to gainers, we’ve got Microchip Technology Inc. (NASDAQ:MCHP), whose stock has gained over 7% so far today on the back of the company reporting its results for the first quarter of fiscal 2017. First-quarter EPS of $0.84 beat the Street’s consensus by $0.10, while revenue of $843.99 million, advanced by 58.1% year-over-year, and topped the estimates by $22.58 million. The EPS established a new record for the company, same as the reported operating income of $231.1 million and the net income from continuing operations of $194 million. Gross margins hit 55.8%. For the second quarter, Microchip Technology projects revenue of $844 million to $877.8 million, EPS of $0.83 to $0.91, and a gross margin between 55.6% and 56.2%. Finally, the team announced an 0.1% increase in the stock’s dividend to $0.36 per share. At the end of March, 16 funds in our database were long Microchip Technology Inc. (NASDAQ:MCHP).

Endo Intl. Investors Rejoice On Double Beat

Finally, there’s Endo International plc – Ordinary Shares (NASDAQ:ENDP), which has skyrocketed 20.40%, driven by better than expected results delivered by the company. Second-quarter EPS of $0.86 and revenue of $921 million beat the Street’s consensus by $0.12 and $56.66 million, respectively. In addition, the company reaffirmed its full-year guidance, which includes sales in the range of $3.87 billion to $4.03 billion, versus analysts’ estimates of $3.93 billion, and EPS of $4.50 to $4.80, compared to analysts’ consensus of $4.54. As of the end of March, 49 hedge funds in our database hold long equity positions in Endo International plc – Ordinary Shares (NASDAQ:ENDP), with the total value of their holdings hitting approximately $1.3 billion.

Disclosure: Javier Hasse holds no interest in any of the securities or entities mentioned above.